Exploratory pharmacodynamics and efficacy of PF-06817024 in a Phase 1 study of patients with chronic rhinosinusitis and atopic dermatitis

MLA

Spencer I. Danto, et al. “Exploratory Pharmacodynamics and Efficacy of PF-06817024 in a Phase 1 Study of Patients with Chronic Rhinosinusitis and Atopic Dermatitis.” Allergy, Asthma & Clinical Immunology, vol. 20, no. 1, Aug. 2024, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s13223-024-00894-8.

APA

Spencer I. Danto, Nikolaos Tsamandouras, Padma Reddy, Steven A. Gilbert, Jessica Y. Mancuso, Karen Page, Jean S. Beebe, Elena Peeva, & Michael S. Vincent. (2024). Exploratory pharmacodynamics and efficacy of PF-06817024 in a Phase 1 study of patients with chronic rhinosinusitis and atopic dermatitis. Allergy, Asthma & Clinical Immunology, 20(1), 1–8. https://doi.org/10.1186/s13223-024-00894-8

Chicago

Spencer I. Danto, Nikolaos Tsamandouras, Padma Reddy, Steven A. Gilbert, Jessica Y. Mancuso, Karen Page, Jean S. Beebe, Elena Peeva, and Michael S. Vincent. 2024. “Exploratory Pharmacodynamics and Efficacy of PF-06817024 in a Phase 1 Study of Patients with Chronic Rhinosinusitis and Atopic Dermatitis.” Allergy, Asthma & Clinical Immunology 20 (1): 1–8. doi:10.1186/s13223-024-00894-8.